Randomized, Controlled Trial Demonstrates the Power of Open-Label Placebos

Patients in the open-label placebo group consumed approximately 30 percent less opioid pain medication than their counterparts who received treatment as usual, while still reporting slightly lower daily pain scores.
Source: BWH News - Category: Hospital Management Source Type: news